Speaker Name: 
GU Oncology Debates 1) Docetaxel vs. Abiraterone in Metastatic Hormone Sensitive Prostate Cancer; 2) 1st Line Treatment in Good Risk Metastatic Renal Cell Carcinoma Daniel J. George, MD Professor Division of Medical Oncology Director, GU Oncology Du
143 Jones Bldg
Durham, NC 27701
United States
Session date: 
Wednesday, May 30, 2018 - 7:30am to 9:00am
  • 1.50 AMA PRA Category 1 Credit(s)
  • 1.50 Attendance

Please login or register to take this course.